Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | ||
| NCT00541905 | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia | ||
| NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT07018713 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea | ||
| NCT00430963 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | ||
| NCT07486830 | IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT01098019 | Treatment of Notalgia Paresthetica With Xeomin | ||
| NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring | ||
| NCT04075981 | Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | ||
| NCT01261741 | Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems | ||
| NCT00694148 | Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | ||
| NCT04210258 | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face | ||
| NCT02207946 | Botulinum Toxin A to Treat Arm Tremor | ||
| NCT01999894 | Open-label Study of Safety and Tolerability of Memantine in Children With Autism | ||
| NCT00773591 | Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders | ||
| NCT00649220 | Memantine and Antipsychotics Use | ||
| NCT00406367 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm | ||
| NCT05884528 | Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia | ||
| NCT04177212 | Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | ||
| NCT00661440 | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT05585398 | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods | ||
| NCT00432666 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb | ||
| NCT00405886 | Neramexane for Tinnitus | ||
| NCT04908423 | Xeomin® and Gait Related Mobility After Stroke | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT06381999 | Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool | ||
| NCT00827008 | Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus | ||
| NCT00978614 | Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects | ||
| NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | ||
| NCT01486264 | Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex | ||
| NCT00712283 | Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT00799942 | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT00429520 | Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds | ||
| NCT00624026 | Memantine - Communication Study | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | ||
| NCT01714960 | Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients | ||
| NCT01603459 | Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm | ||
| NCT00465738 | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity |
